Effective parenteral antibiotic regimens benefit patients with cutaneous, neurologic, cardiac, or joint features of Lyme disease. However, in patients whose only evidence for Lyme disease is a positive immunologic test result, the risks for empiric, intravenous antibiotic treatment outweigh the benefits.
|Original language||English (US)|
|Number of pages||1|
|Journal||Annals of internal medicine|
|State||Published - Jan 1 1993|
ASJC Scopus subject areas
- Internal Medicine